CHUGAI PHARMACEUTICAL CO., LTD.

Print

Translation

Apr 27, 2017

Name of listed company:   Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Osamu Nagayama
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.
  Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Announces First Quarter Sales 2017

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its First quarter sales 2017 (January 1 - March 31, 2017).
Roche owns 59.89% of Chugai's outstanding shares (61.35% of the total number of shares issued excluding treasury stock) as of end of March 2017.
The press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to March 31, 2017 is included in the announced Roche Group’s results.

Media Releases Investor Updates Presentation
 

[ PDF 72KB]

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Close